Pharmacotherapy of lupus nephritis: time for a consensus?

Author： Perysinaki Garyfallia   Panagiotakis Simeon   Bertsias George   Boumpas Dimitrios T  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.12, 2008-08, pp. : 2099-2115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of Lupus Nephritis in Children: A Recommended Treatment Approach

By Adams Alexa   Emma Jane MacDermott   Lehman Thomas J.A.  

Drugs, Vol. 66, Iss. 9, 2006-01 ,pp. : 1191-1207

Adis International

Access to resources Recommend Favorite

Animal Models of Lupus and Lupus Nephritis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. : 2320-2349

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of systemic lupus erythematosus

By Francis Lisa   Perl Andras  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1481-1494

Informa Healthcare

Access to resources Recommend Favorite

Infliximab: Lupus nephritis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1243, 2009-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite

Etanercept: Lupus nephritis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1216, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite